Aghsami, Mehdi <br/><br/>
A cAMP analog attenuates beta-amyloid (1-42)-induced mitochondrial dysfunction and spatial learning and memory deficits.  [electronic resource] 

 -  Brain research bulletin  06 2018 
 - 34-42 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-2747 
<br/><br/><label>Standard No.: </label>10.1016/j.brainresbull.2018.03.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--drug therapy<br/>Amyloid beta-Peptides--metabolism<br/>Animals<br/>Antioxidants--pharmacology<br/>Bucladesine--pharmacology<br/>Cyclic AMP--analogs & derivatives<br/>Disease Models, Animal<br/>Hippocampus--drug effects<br/>Male<br/>Maze Learning--drug effects<br/>Memory Disorders--drug therapy<br/>Mitochondria--drug effects<br/>Mitochondrial Diseases--drug therapy<br/>Neuroprotective Agents--pharmacology<br/>Nootropic Agents--pharmacology<br/>Oxidative Stress--drug effects<br/>Peptide Fragments--metabolism<br/>Rats, Wistar<br/>Spatial Memory--drug effects